Molecular formula: | C32H40N4O5S |
Average mass: | 592.755 |
Monoisotopic mass: | 592.271941 |
ChemSpider ID: | 8433365 |
254740-64-2
[RN]4′-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2′-(ethoxymethyl)(1,1′-biphenyl)-2-sulfonamide
4′-({2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl}methyl)-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)-[1,1′-biphenyl]-2-sulfonamide
4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)-2-biphenylsulfonamid
[German]
[ACD/IUPAC Name]4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)-2-biphenylsulfonamide
[ACD/IUPAC Name]4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-én-3-yl)méthyl]-N-(4,5-diméthyl-1,2-oxazol-3-yl)-2′-(éthoxyméthyl)-2-biphénylsulfonamide
[French]
[ACD/IUPAC Name]4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)biphenyl-2-sulfonamide
[1,1′-Biphenyl]-2-sulfonamide, 4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(ethoxymethyl)-
[ACD/Index Name]esparsentán
[Spanish]
[INN]sparsentan
[INN] [USAN]sparsentan
[French]
[INN]sparsentanum
[Latin]
[INN]Спарсентан
[Russian]
[INN]سبارسينتان
[Arabic]
[INN]司帕生坦
[Chinese]
[INN]1-(Dimethylamino)cyclopentanecarbonitrile
[ACD/IUPAC Name]2-[4-({2-BUTYL-4-OXO-1,3-DIAZASPIRO[4.4]NON-1-EN-3-YL}METHYL)-2-(ETHOXYMETHYL)PHENYL]-N-(DIMETHYL-1,2-OXAZOL-3-YL)BENZENESULFONAMIDE
2-[4-[(2-butyl-4-keto-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethylisoxazol-3-yl)benzenesulfonamide
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-3-isoxazolyl)benzenesulfonamide
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethylisoxazol-3-yl)benzenesulfonamide
4′-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-2′-ethoxymethyl-biphenyl-2-sulfonic acid (4,5-dimethyl-isoxazol-3-yl)-amide
4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(ethoxymethyl)-[1,1′-biphenyl]-2-sulfonamide
4″-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-2″-ethoxymethyl-biphenyl-2-sulfonic acid (4,5-dimethyl-isoxazol-3-yl)-amide
MFCD16628036
[MDL number]sparsentan (re-021)